PDB Entry - 8CXC
(Status - Released)Summary information:
Title: Novel Anti-Mesothelin Antibodies Enable Crystallography of the Intact Mesothelin Ectodo- main and Engineering of Potent, T cell-engaging Bispecific Therapeutics
PDB DOI: https://doi.org/10.2210/pdb8cxc/pdb
Primary publication DOI: https://doi.org/10.3389/fddsv.2023.1216516
Entry authors: Bandaranayake, A.D., Rupert, P.B., Lin, I., Pilat, K., Ruff, R.O., Friend, D.J., Chan, M.K., Clarke, M., Carter, J., Meshinchi, S., Mehlin, C., Olson, J.M., Strong, R.K., Correnti, C.E.
Initial deposition on: 20 May 2022
Initial release on: 7 June 2023
Latest revision on: 30 October 2024
Downloads:
Structure coordinates (PDBx/mmCIF)
Structure coordinates (PDBML)
Structure coordinates (PDB)
X-ray diffraction data (PDBx/mmCIF)
Validation report (XML)
Validation report (PDF)
Validation report (mmCIF)
Links to more resources for 8CXC at: